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INTRODUCTION
C1q nephropathy is a proliferative glomerulopathy char-
acterized by extensive C1q mesangial deposition in the clin-
ical setting of steroid-resistant proteinuria (1). So far, its eti-
ology is not well-known, and the case reports associated with
infection have been rare. Epstein-Barr virus (EBV) is a ubiq-
uitous human herpes virus that causes infectious mononu-
cleosis. In addition to the classic triad of fever, pharyngitis,
and lymphadenopathy, patients with infectious mononucle-
osis due to acute EBV infection may develop various com-
plications in various organs including hemolytic anemia,
granulocytopenia, hepatitis, pericarditis, encephalitis, and
acute interstitial nephritis (2, 3). In addition, development
of glomerulonephritis in a patient with chronic active EBV
infection has been also reported (4). 
A three-year old boy with proteinuria during acute phase
of infectious mononucleosis went through a renal biopsy, and
the pathologic findings were compatible with C1q nephropa-
thy. There has been no report of C1q nephropathy develop-
ing in association with EBV infection. Furthermore, the fam-
ily history of Dent’s disease incurred more confusion into
the evaluation of proteinuria.
CASE REPORT
A three-year old, previously healthy boy was brought to us
because of intermittent fever for seven days and foamy urine
for five days. On admission, his body temperature was 39.5℃
and blood pressure was 100/60 mmHg. The throat was mild-
ly injected without exudate or ulceration. A few thumb tip-
sized cervical lymph nodes were detected bilaterally, which
were non-tender and movable. Both liver and spleen were
palpable with three finger-breaths. The edge of the liver was
sharp, and the surface was smooth without tenderness. The
urogenital examination was normal. One of his maternal
cousins had proteinuria since age of three and was diagnosed
as having Dent’s disease by genetic testing. His maternal
grandfather also had a history of proteinuria since childhood,
and developed chronic renal failure several years before.
Initial laboratory investigations revealed: hemoglobin 10.4
g/dL, platelet 191,000/ L, and WBC 24,710/ L (neutrophils
21%, lymphocytes 44%, atypical lymphocytes 28%, and
monocytes 7%). The blood biochemistry results were as fol-
lows; blood urea nitrogen 11 mg/dL, creatinine 0.4 mg/dL,
total protein 7.4 g/dL, albumin 4.2 g/dL, and aspartate ami-
notransferase, alanine aminotransferase, and alkaline phos-
phatase were 98, 153, and 565 IU/L, respectively. EBV VCA
IgM Ab was positive, and other viral markers including hep-
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Proteinuria in a Boy with Infectious Mononucleosis, C1q Nephropathy,
and Dent’ s Disease
C1q nephropathy is a proliferative glomerulopathy with extensive mesangial depo-
sition of C1q. A three-year old boy presented with a nephrotic-range proteinuria
during an acute phase of Epstein-Barr virus (EBV) infection, and he had a family
history of Dent’s disease. The renal biopsy findings were compatible with C1q
nephropathy. However, EBV in situ hybridization was negative. The CLCN5 gene
analysis revealed an R637X hemizygous mutation, which was the same as that
detected in his maternal cousin, the proband of the family. The causal relationship
between EBV infection and C1q nephropathy remains to be determined. More-
over, the effects of underlying Dent’s disease in the process of C1q nephropathy
has to be considered.
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atitis B virus, hepatitis C virus, hepatitis A virus and cyto-
megalovirus were all negative. Urinalysis revealed two posi-
tive albuminuria with some hyaline and granular casts, but
hematuria was not detected. Urinary protein excretion was
2,780 mg/day, and urinary calcium excretion was 2.7 mg/kg/
day. Urinary  2-microglobulin was 163  g/mL. The urinary
protein electrophoresis revealed: albumin 34.9% and total
globulin 65.1%. The SDS-PAGE of urine protein showed a
mixed glomerular and tubular pattern of proteinuria. Serum
C3 and C4 were 213.8 and 71.5 mg/dL, respectively. Serum
IgG, IgA, and IgM were 1,590, 153, and 230 mg/dL, respec-
tively. ASO titer, anti-double strands-DNA, and rheumatoid
factor were negative. Renal ultrasonography revealed no ab-
normal findings.
Initially, EBV infection was easily diagnosed on the basis
of typical clinical features and the positive serologic test. In
addition, severe low-molecular weight proteinuria support-
ed the possibility of underlying Dent’s disease. However,
nephrotic range proteinuria with a considerable proportion
of albuminuria could not be explained by EBV infection
and/or underlying Dent’s disease. Thus, kidney biopsy was
carried out to rule out a superimposing glomerular disease.
Total nineteen glomeruli were identified by light micro-
scopic examination of the biopsied renal tissue. The glome-
ruli, tubules, interstitium, and blood vessels looked almost
normal. However, electron microscopic examination disclos-
ed a small amount of mesangial deposits with focal moder-
ate effacement of epithelial foot processes. Immunofluores-
Fig. 1. (A) Light microscopic finding of the renal biopsy shows a
glomerulus of normal size and cellularity (periodic acid-Schiff sta-
in; original magnification, ×400). (B) Immunofluorescence micro-
scopic examination reveals dominant mesangial staining of C1q
(original magnification, ×200). (C) Electron microscopic exami-
nation shows some mesangial electron-dense deposits (original
magnification, ×3,500).
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cence microscopic examination revealed mesangial C1q (++)
and IgG (+) deposits with a granular pattern (Fig. 1). In situ
hybridization of EBV was negative (data not shown). 
The mutational analysis of the CLCN5 gene revealed a C-
to-T point mutation that replaces the 637th codon of argi-
nine to a stop codon. This nonsense mutation was the same
one detected in his maternal cousin previously (the patient 1
in reference 5). 
Leukocytosis and abnormal liver function were normalized
within seven days with conservative management, and aty-
pical lymphocytosis disappeared completely within three
weeks. However, proteinuria persisted, and enalapril (2 mg/
kg/day) was started by the twentieth day of hospitalization,
which decreased the urine protein/creatinine ratio by approxi-
mately 50% a after six months.
Follow-up of EBV serologic markers after a month reveal-
ed positive VCA-IgM, VCA-IgG, and EA(DR)-IgG anti-
bodies. About five months later, negative conversion of VCA-
IgM Ab and positive conversion of EBNA-IgG Ab were
noted.
DISCUSSION
C1q nephropathy is a controversial disease entity that was
first defined by its unusual immunopathologic characteris-
tics (1). Mostly acceptable diagnostic criteria of C1q nephro-
pathy are mesangial immune deposits that stain dominantly
or co-dominantly for C1q, corresponding mesangial electron
dense deposits on electron microscopic examination, and the
clinical setting of steroid-resistant proteinuria without evi-
dence of systemic lupus erythematosus (1, 6, 7). The light
microscopic findings are traditionally accepted by focal seg-
mental glomerulosclerosis in most patients and minimal ch-
ange lesion in others (7). However, some recent studies sug-
gested that C1q nephropathy was an entity that histological-
ly is within the minimal change disease or a Focal Segmen-
tal Glomeanlosclerosis (FSGS) and appears to show the full
spectrum of histological variants seen in FSGS (8, 9).
Our patient fully met the above diagnostic criteria. The
pathogenesis of C1q nephropathy is mostly unclear. Although
there was a case report (10) of de novo C1q nephropathy in
a graft kidney in association with human polyoma (BK) virus
interstitial nephritis, association with other virus including
EBV was absent. Lee et al. (11) reported a case of C1q nephro-
pathy in a 23-month-old girl with steroid-dependent nephrot-
ic syndrome as the first case in Korea.
EBV infection may induce renal diseases, most frequently
acute interstitial nephritis during the course of infectious
mononucleosis. Occasional occurrences of glomerular dis-
eases such as IgA nephropathy, steroid-dependent minimal
change nephrotic syndrome, and hemolytic uremic syndrome
in patients with infectious mononucleosis have also been
reported (12). In addition, post-transplant lymphoprolifera-
tive disorders caused by EBV frequently involve the graft
(13). Although there have been no previous case report of
C1q nephropathy in association with infectious mononucle-
osis and a the in situ hybridization result was negative, the
causal relationship between EBV infection and C1q nephropa-
thy cannot be completely excluded in our patient on the
basis of coincidental onset of infectious mononucleosis and
the foamy urine and the frequent negative result of in situ
hybridization in EBV-induced nephritis (3). 
There has been controversies about the effect of steroid
treatment for C1q nephropathy (1, 6, 14, 15). In our patient,
steroid therapy was not undertaken due to active EBV infec-
tion. Instead, enalapril treatment resulted in partial reduc-
tion of proteinuria.
Dent’s disease, a renal tubular disorder caused by inacti-
vating mutations in the CLCN5 gene encoding the ClC-5
chloride channel expressed in tubular epithelial cells, is char-
acterized by low-molecular-weight proteinuria, hypercalci-
uria, nephrocalcinosis/nephrolithiasis, and progressive renal
failure (5, 16, 17). The tubular component of proteinuria in
our patient was thought to have resulted from underlying
Dent’s disease. The possible harmful influence of underly-
ing Dent’s disease on the course of C1q nephropathy should
be determined by a long-term follow-up of the patient.
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